LifeVantage (NASDAQ:LFVN – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, January 28th. Analysts expect the company to announce earnings of $0.14 ...

In a report released today, Alex Fuhrman from Craig-Hallum assigned a Buy rating to LifeVantage (LFVN – Research Report). The company’s shares ...

The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients ...

Their product line includes the Protandim® family, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and various other health supplements and skin care products. The company markets its ...

The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting ...

Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy recommendation. Analyst Price Forecast Suggests 3.07% Upside As of December 23, 2024, ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

The company adopted its current name in November 2006. Initially focused on selling a single product, Protandim, through traditional retail stores from 2005 to 2009, LifeVantage transitioned to a ...

The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients ...

LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer and the MindBody GLP-1 System. The findings reveal that when used ...